![Matthew Gall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Gall
Directeur Financier/CFO chez
TANGO THERAPEUTICS, INC.
Profil
Matthew Gall is currently Chief Financial Officer at Tango Therapeutics, Inc. since 2026.
Formerly, Mr. Gall was Chief Financial Officer & Treasurer at Kalaris Therapeutics, Inc. from 2025 to 2026, Chief Financial Officer at iTeos Therapeutics, Inc. from 2020 to 2025, and Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.
Postes actifs de Matthew Gall
| Sociétés | Poste | Début |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Directeur Financier/CFO | 15/04/2026 |
Anciens postes connus de Matthew Gall
| Sociétés | Poste | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Directeur Financier/CFO | 28/08/2025 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Formation de Matthew Gall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Bowling Green State University
 Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
